Why the study?
Does trimethadione exposure during pregnancy cause fetal loss and congenital malformations?
Does trimethadione exposure during pregnancy cause fetal loss and congenital malformations?
Trimethadione and related drugs are highly teratogenic, causing a distinct syndrome of fetal loss and malformations (including cardiac defects), and should be withheld during pregnancy.
Answers are grounded in this paper and cite their sources.
Supports caution with trimethadione in pregnancy; leaves open confirmation from controlled studies.
We describe a family in which seven pregnancies resulted in four infants who died and in three abortions. During these pregnancies the mother took trimethadione (Tridione), as well as other anticonvulsants. Two normal children were born after treatment with all medications were stopped. There have now been 53 reported pregnancies in which the fetuses were exposed to trimethadione or paramethadione; 48 (87%) resulted in fetal loss or a child born with congenital malformations. The most common defects include malformed ears, cleft palate, cardiac defects, urogenital malformations, and skeletal abnormalities. Delayed mental and physical development were also seen. These findings constitute a clinical entity termed the fetal trimethadione syndrome. The malformation rate is believed to be due to the teratogenic effects of trimethadione. Physicians need to be aware of the danger of trimethadione and related drugs during pregnancy and should withhold these medications during this period.
No takes yet. Share an insight, caveat, or question.
Gerald L. Feldman (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: